CHEN Yimeng,CHEN Yuye,YU Guangchun,et al.Effect of Xiaoqinglong Decoction (小青龙汤) on Th2 Immune Responses and Nasal Mucosal TSLP/OX40L Pathway in Allergic Rhinitis Model Rats[J].Journal of Traditional Chinese Medicine,2026,67(09):994-1002.
CHEN Yimeng,CHEN Yuye,YU Guangchun,et al.Effect of Xiaoqinglong Decoction (小青龙汤) on Th2 Immune Responses and Nasal Mucosal TSLP/OX40L Pathway in Allergic Rhinitis Model Rats[J].Journal of Traditional Chinese Medicine,2026,67(09):994-1002.DOI: 10.13288/j.11-2166/r.2026.09.012.
Effect of Xiaoqinglong Decoction (小青龙汤) on Th2 Immune Responses and Nasal Mucosal TSLP/OX40L Pathway in Allergic Rhinitis Model Rats
Forty-five rats were randomly assigned to a control group, a model group, a loratadine group, low-, medium- and high-dose XD groups, and low-, medium- and high-dose
Mahuang Decoction and Cang'erzi Powder
(麻黄汤合苍耳子散, MDCP) groups. Except for the control group, rats were administered with ovalbumin (OVA) and aluminum hydroxide via intraperitoneal injection for 14 days to establish an allergic rhinitis model. After the 14th-day injection, nasal stimulation was continued with 20 μl of 10% OVA solution to maintain the model. Rats in the control group and the model group received 10 ml/(kg·d) of saline, whereas those in the loratadine group were administered with 0.9 mg/(kg·d) of loratadine. The low-, medium- and high-dose XD groups were administered XD at the dose of 2.7, 5.4, and 10.8 g/(kg·d), respectively. The low-, medium- and high-dose MDCP groups were administered MDCP at the dose of 2.43, 4.86, and 9.72 g/(kg·d), respectively. All treatments were administered by gavage once daily for 7 consecutive days. One hour after the final gavage, nasal symptom scores were recorded for all group of ra
ts. The next day, serum levels of immunoglobulin E (IgE), interleukin-4 (IL-4), and interleukin-13 (IL-13) were measured. HE staining was used to observe the pathological morphology of the nasal mucosal tissue. Quantitative reverse transcription PCR (RT-qPCR) and Western Blot were performed to assess mRNA and protein expression of thymic stromal lymphopoietin (TSLP) and OX40 ligand (OX40L) in the nasal mucosa.
Results
2
Compared to the control group, total nasal symptom score in the model group significantly increased (
P
<0.01). HE staining revealed disrupted and adhered cilia, thickened basement membranes, and extensive inflammatory cell infiltration in the nasal mucosa. Serum levels of total IgE, IL-4, and IL-13, as well as
TSLP
and
OX40L
mRNA and protein expression in the nasal mucosa, were significantly elevated in the model group (
P
<0.05 or
P
<0.01). Compared to the model group, the total nasal symptom scores in all drug intervention groups were significantly reduced; the serum total IgE levels in the loratadine group, the low- and medium-dose XD groups, and the low- and high-dose MDCP groups were significantly reduced; and the serum levels of IL-4 and IL-13 in the high-dose XD group and the high-dose MDCP group decreased (
P
<0.05 or
P
<0.01). Nasal mucosal structure was improved. Except for the low-dose MDCP group, all other intervention groups showed a significant reduction in
TSLP
and
OX40L
mRNA expression in the nasal mucosa (
P
<0.01). All doses of XD and the medium- and high-dose MDCP groups significantly decreased the protein levels of TSLP and OX40L (
P
<0.05). The medium-dose XD group exhibited more improvement of nasal symptom scores and greater suppression of expression of
TSLP
and
OX40L
mRNA, and TSLP
protein levels compared to the loratadin
e group (
P
<0.05).
Conclusion
2
XD may protect nasal mucosa of rats and alleviate allergic rhinitis by suppressing the TSLP/OX40L pathway, thereby attenuating Th2-mediated immune responses.
关键词
Keywords
references
WANG C S , BAO Y X , CHEN J J , et al . Chinese guideline on allergen immunotherapy for allergic rhinitis: the 2022 update [J]. Allergy Asthma Immunol Res , 2022 , 14 ( 6 ): 604 - 652 .
SESHASAYEE D , LEE WP , ZHOU M , et al . In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation [J]. J Clin Invest , 2007 , 117 ( 12 ): 3868 - 3878 .
SENTURK E , YILDIRIM Y S , DOGAN R , et al . Assessment of the effectiveness of cyclosporine nasal spray in an animal model of allergic rhinitis [J]. Eur Arch Otorhinolaryngol , 2018 , 275 ( 1 ): 117 - 124 .
LIU Y J , SOUMELIS V , WATANABE N , et al . TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation [J]. Annu Rev Immunol , 2007 , 25 : 193 - 219 . doi: 10.1146/annurev.immunol.25.022106.141718 http://dx.doi.org/10.1146/annurev.immunol.25.022106.141718 .
LI D Q , ZHANG L , PFLUGFELDER S C , et al . Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways [J]. J Allergy Clin Immunol , 2011 , 128 ( 6 ): 1318 - 1325.e2 .
TACHDJIAN R , MATHIAS C , KHATIB SAL , et al . Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma [J]. J Exp Med , 2009 , 206 ( 10 ): 2191 - 2204 .
GOULD H J , SUTTON B J , BEAVIL A J , et al . The biology of IgE and the basis of allergic disease [J]. Annu Rev Immunol , 2003 , 21 : 579 - 628 . doi: 10.1146/annurev.immunol.21.120601.141103 http://dx.doi.org/10.1146/annurev.immunol.21.120601.141103 .
SIDDIQUI Z A , WALKER A , PIRWANI M M , et al . Allergic rhinitis: diagnosis and management [J]. Br J Hosp Med (Lond) , 2022 , 83 ( 2 ): 1 - 9 .
BERNSTEIN D I , SCHWARTZ G , BERNSTEIN J A . Allergic rhinitis: mechanisms and treatment [J]. Immunol Allergy Clin North Am , 2016 , 36 ( 2 ): 261 - 278 .
NUR HUSNA S M , MD SHUKRI N , MOHD ASHARI N S , et al . IL-4/IL-13 axis as therapeutic targets in allergic rhinitis and asthma [J]. PeerJ , 2022 , 10 : e13444 . doi: 10.7717/peerj.13444 http://dx.doi.org/10.7717/peerj.13444 .
MENG Q , LIU X , LI P , et al . The influence of house dust mite sublingual immunotherapy on the TSLP-OX40L signaling pathway in patients with allergic rhinitis [J]. Int Forum Allergy Rhinol , 2016 , 6 ( 8 ): 862 - 870 .
Treatment of Allergic Rhinitis Based on the Theory of "Harmful Hyperactivity and Responding Inhibition, and Extreme Fire Resembling Water"
Differentiation and Treatment of Pediatric Allergic Rhinitis Based on the Theory of "Spleen Fuctions as Wei Qi"
Garlic Moxibustion with Herbal Medicinals in the Treatment of 35 Cases of Allergic Rhinitis with Latent Heat in Lung Meridian Syndrome:A Randomized Controlled Trial
Professor CAO Hongxin's Experience in Syndrome Differentiation and Treatment of Allergic Rhinitis
Effects of Bimin Formula (鼻敏方) on the Nasal Mucosa TMEM16A/NF-κB/MUC5AC Signaling Pathway in a Rat Model of Allergic Rhinitis with Lung-Spleen Qi Deficiency
Related Author
LING Guoxing
FU Yanling
DONG Haihang
HUANG Sheng
SUN Chaofan
SUN Chunquan
GAO Huijuan
FENG Xingzhong
Related Institution
Xiyuan Hospital,China Academy of Chinese Medical Sciences
Beijing University of Chinese Medicine
Yuquan Hospital,Tsinghua University
School of Pediatrics,Henan University of Traditional Chinese Medicine
Department of Pediatrics,The First Affiliated Hospital of Henan University of Traditional Chinese Medicine